TIRZEPATIDE 30MG
30mg · 2ml vial · 12 weeks (dose dependent)
Tirzepatide is a once-weekly injectable that activates both GLP-1 and GIP receptors, producing strong appetite suppression, improved glucose control, and substantial weight loss.
It is one of the most clinically validated metabolic peptides available and the foundation of most modern medical weight-management protocols.
Physical label displays 7.5mg/0.5ml in a 2ml vial size, for a total content of 30mg.
Medical compliance
All medications are physician-prescribed following individual evaluation and dispensed by US-licensed 503A compounding pharmacies. Statements have not been evaluated by the FDA. Information on this page is for educational purposes only and is not a substitute for professional medical advice. Use only under qualified medical supervision.